849 assets in Breast Cancer

Therapeutic assets addressing Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
68ga-my Breast Cancer	Peking University Cancer Hospital & Institute	N/A	D (26)
68ga-nota-nectin-4 antibody fragment Breast Cancer	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	N/A	D (26)
Blood, Whole Breast Cancer	UNC Lineberger Comprehensive Cancer Center	N/A	D (26)
Capsaicin Breast Cancer	Institut Toulousain d'Ostéopathie	N/A	D (26)
Carbon Black Breast Cancer	Gaziosmanpasa Research and Education Hospital	N/A	D (26)
Carbon Nanoparticle Suspension Breast Cancer	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A	D (26)
Cefazolin Breast Cancer	Cairo University	N/A	D (26)
Copper Cu 64 Anti-Cea Monoclonal Antibody M5A Breast Cancer	City of Hope Medical Center	N/A	D (26)
Declaran Breast Cancer	Centro di Riferimento Oncologico - Aviano	N/A	D (26)
Dota-Fapi-04 Gallium Ga-68 Breast Cancer	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	N/A	D (26)
Fenofibrate Breast Cancer	Damanhour University	N/A	D (26)
Glucose, Anhydrous Breast Cancer	Rutgers, The State University of New Jersey	N/A	D (26)
Magseed Breast Cancer	Vastra Gotaland Region	N/A	D (26)
Magtrace Breast Cancer	Vastra Gotaland Region	N/A	D (26)
Montelukast Breast Cancer	Damanhour University	N/A	D (26)
Nalbuphine Breast Cancer	Aga Khan University	N/A	D (26)
Panthenol Breast Cancer	Angelos Kassianos	N/A	D (26)
Promestriene Breast Cancer	Federal University of São Paulo	N/A	D (26)
Qibei Jiedu Formula Breast Cancer	LI FENG	N/A	D (26)
Shenbailing Breast Cancer	Caigang Liu	N/A	D (26)
Tapentadol Breast Cancer	Shaukat Khanum Memorial Cancer Hospital & Research Centre	N/A	D (26)
Technetium, Tc-99M Breast Cancer	Isabelle Henskens	N/A	D (26)
Technetium Tc 99M Sestamibi Breast Cancer	M.D. Anderson Cancer Center	N/A	D (26)
Xihuang Pill Breast Cancer	Zhejiang Provincial People's Hospital	N/A	D (26)
[18F]SF-DEVD-2 Breast Cancer	Affiliated Hospital of Jiangnan University	Early P1	NR ()
Abbv-400 Breast Cancer	AbbVie	P1	NR ()
cgt6297 Breast Cancer	Cogent Biosciences, Inc.	P1	NR ()
Convitvax Breast Cancer	Jacinto Convit World Organization Inc.	P1/2	NR ()
Enitinostat Breast Cancer	Beijing 302 Hospital	P2	NR ()
Fuzaparib Breast Cancer	Xijing Hospital	P2	NR ()
Gcmaf Injections Breast Cancer	S.LAB (SOLOWAYS)	P3	NR ()
hp568 Breast Cancer	Hinova Pharmaceuticals Inc.	P1/2	NR ()
Hrs-6208 Breast Cancer	Shandong Suncadia Medicine Co., Ltd.	P1/2	NR ()
hs-10342 Breast Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P2	NR ()
Lignocaine Breast Cancer	Tata Memorial Hospital	P3	NR ()
ots167po Breast Cancer	OncoTherapy Science, Inc.	P1	NR ()
Pcbhp Breast Cancer	Fudan University	P3	NR ()
Pert-Ijs Breast Cancer	Biocon Biologics UK Ltd	P3	NR ()
QLS1304 Breast Cancer	Qilu Pharmaceutical Co., Ltd.	P1/2	NR ()
Rem-001 Photodynamic Therapy Breast Cancer	Kintara Therapeutics, Inc.	P2	NR ()
Talniflumate Breast Cancer	Shandong University	P4	NR ()
Tgfbr2 Ko Ic9/Trop2.Car/Il-15 Nk Cells Breast Cancer	M.D. Anderson Cancer Center	P1	NR ()
Tirelizumab Breast Cancer	Fudan University	P2	NR ()
Trop2.Car Breast Cancer	M.D. Anderson Cancer Center	P1	NR ()

Showing 801 to 849 of 849 assets

PreviousPage 17 of 17Next